Qualitative and Quantitative Performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in Patients with Head and Neck Cancer

REFERENCES

1. 1.↵
   2. Ferlay J,
   3. Shin HR,
   4. Bray F, et al

   . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Curado MP,
   3. Hashibe M

   . Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 2009;21:194–200

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Guntinas-Lichius O,
   3. Wendt T,
   4. Buentzel J, et al

   . Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 2010;136:55–63

   CrossRefPubMed
4. 4.↵
   2. Tulunay-Ugur OE,
   3. McClinton C,
   4. Young Z, et al

   . Functional outcomes of chemoradiation in patients with head and neck cancer. Otolaryngol Head Neck Surg 2013;148:64–68

   Abstract/FREE Full Text
5. 5.↵
   2. Eiber M,
   3. Souvatzoglou M,
   4. Pickhard A, et al

   . Simulation of a MR-PET protocol for staging of head-and-neck cancer including Dixon MR for attenuation correction. Eur J Radiol 2012;81:2658–65

   CrossRefPubMed
6. 6.↵
   2. Ishikita T,
   3. Oriuchi N,
   4. Higuchi T, et al

   . Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy. Ann Nucl Med 2010;42:77–82
7. 7.↵
   2. Iyer NG,
   3. Clark JR,
   4. Singham S, et al

   . Role of pretreatment 18FDG-PET/CT in surgical decision-making for head and neck cancers. Head Neck 2010;32:1202–08

   CrossRefPubMed
8. 8.↵
   2. Jeong HS,
   3. Baek CH,
   4. Son YI, et al

   . Use of integrated [18F]-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 2007;29:203–10

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Ng SH,
   3. Yen TC,
   4. Chang JT, et al

   . Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006;24:4371–76

   Abstract/FREE Full Text
10. 10.↵
    2. Kershah S,
    3. Partovi S,
    4. Traughber BJ, et al

    . Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population. Mol Imaging Biol 2013;15:776–85

    CrossRefPubMed
11. 11.↵
    2. Heusch P,
    3. Buchbender C,
    4. Beiderwellen K, et al

    . Standardized uptake values for [18F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. Eur J Radiol 2013;82:870–76

    CrossRefPubMed
12. 12.↵
    2. Partovi S,
    3. Kohan A,
    4. Gaeta C, et al

    . Image quality assessment of automatic three-segment MR attenuation correction vs. CT attenuation correction. Am J Nucl Med Mol Imaging 2013;3:291–99

    PubMed
13. 13.↵
    2. Schulz V,
    3. Torres-Espallardo I,
    4. Renisch S, et al

    . Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging 2011;38:138–52

    CrossRefPubMed
14. 14.↵
    2. Landis JR,
    3. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Buchbender C,
    3. Heusner TA,
    4. Lauenstein TC, et al

    . Oncologic PET/MRI. Part 1. Tumors of the brain, head and neck, chest, abdomen, and pelvis. J Nucl Med 2012;53:928–38

    Abstract/FREE Full Text
16. 16.↵
    2. Boss A,
    3. Stegger L,
    4. Bisdas S, et al

    . Feasibility of simultaneous PET/MR imaging in the head and upper neck area. Eur Radiol 2011;21:1439–46

    CrossRefPubMed
17. 17.↵
    2. Hofmann M,
    3. Steinke F,
    4. Scheel V, et al

    . MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 2008;49:1875–83

    Abstract/FREE Full Text
18. 18.↵
    2. de Bree R,
    3. Deurloo EE,
    4. Snow GB, et al

    . Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000;110(pt 1):397–401

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Jones AS,
    3. Morar P,
    4. Phillips DE, et al

    . Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75:1343–53

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Priante AV,
    3. Castilho EC,
    4. Kowalski LP

    . Second primary tumors in patients with head and neck cancer. Curr Oncol Rep 2011;13:132–37

    CrossRefPubMed
21. 21.↵
    2. Platzek I,
    3. Beuthien-Baumann B,
    4. Schneider M, et al

    . PET/MRI in head and neck cancer: initial experience. Eur J Nucl Med Mol Imaging 2013;40:6–11

    CrossRefPubMed
22. 22.↵
    2. Keereman V,
    3. Mollet P,
    4. Berker Y, et al

    . Challenges and current methods for attenuation correction in PET/MR. MAGMA 2013;26:81–98

    CrossRefPubMed